(R)-1-(3-Pyridylthiocarbamoyl)pyrrolidine-2-carboxylic Acid>98.0%(HPLC)(T)100mg

Emballage en verre à eau de potassium, pur, 2,5 l, emballage en plastique.

1-(6-Chloropyridin-2-yl)-2,2,2-trifluoroethanone, 98%, 100mg

4-(thiophen-2-yl)-2,3-dihydro-1H-1,5-benzodiazepine, 95.0%, 2g

Sulfate d'ytterbium hydraté 99,9% 10 g

6-Bromo-4-methoxypicolinic acid, 95.0%, 1g

2-Phenyl-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

tert-Butyl 2-oxo-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 500mg

1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)ethanone, 95.0%, 5g

(4R,4'R)-2,2'-[2-PHENYL-1-(PHENYLMETHYL)ETHYLIDENE]BIS[4-(1-METHYLETHYL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

(4-Vinylphenyl)methanamine (stabilized with MEHQ), 95.0%, 1g

Allyl (2,5-dioxopyrrolidin-1-yl) carbonate, 95.0%, 100g

1-Benzyl-2,2-dimethylpiperidin-4-one, 98%, 5g